) is set to report second quarter 2013 results on Jul 30, before
the opening bell. Last quarter it posted a negative earnings
surprise of 1.82%. Let's see how things are shaping up for this
Factors at Play for 2Q
This global biopharmaceutical company has delivered positive
earnings surprises in three of the last four quarters with an
average beat of 4.91%. Pfizer lowered its earnings and revenue
outlook for 2013 following the divestment of its stake in its
former animal health business,
In the second quarter, genericization will continue to hit
revenues. To mitigate the impact of genericization the company is
looking to contain costs and develop its pipeline. We expect the
company to throw further light on its pipeline development
efforts, while releasing the second quarter results.
Our proven model does not conclusively show that Pfizer is likely
to beat earnings estimates this quarter. This is because a stock
needs to have both a positive earnings Expected Surprise
Prediction or ESP (Read:
Zacks Earnings ESP: A Better Method
) and a Zacks Rank #1, 2 or 3 for this to happen.
: The ESP, which represents the difference between the Most
Accurate estimate and the Zacks Consensus Estimate, is 0.00%.
This is because both the Most Accurate estimate and the Zacks
Consensus Estimate currently stand at 54 cents.
Zacks Rank #3 (Hold)
: Pfizer's Zacks Rank #3, however, increases the predictive power
of ESP. That said we also need to have a positive ESP to be
confident for an earnings surprise call.
Stocks to Consider
Here are some stocks you may want to consider as our model shows
that these have the right combination of elements to post an
earnings beat this season:
) has Earnings ESP of +1.75% and holds a Zacks Rank #2 (Buy).
Amgen will be reporting second quarter earnings on Jul 30 after
the market closes.
) has Earnings ESP of +1.49% and holds a Zacks Rank #3. Mylan
will be reporting second quarter earnings on Aug 1 before the
AMGEN INC (AMGN): Free Stock Analysis Report
MYLAN INC (MYL): Free Stock Analysis Report
PFIZER INC (PFE): Free Stock Analysis Report
ZOETIS INC (ZTS): Free Stock Analysis Report
To read this article on Zacks.com click here.